Blog - QualityStocks

TuesdayJun 09, 2026 9:20 am

QualityStocksNewsBreaks – BOXABL Unveils Conceptual UFO Habitat for Future Lunar and Planetary Settlements

Live on the Moon with BOXABL's UFO Space Habitat BOXABL highlighted UFO (Unidentified Folding Object), a conceptual off-world habitation system designed to address the challenges of transporting and deploying livable structures beyond Earth. The concept, featured in the company's recently released video "LIVE ON THE MOON (Part 1) — UFO by BOXABL," is based on foldable building intellectual property that would allow habitats to launch in a compact configuration and expand into larger living spaces after deployment. BOXABL UFO- Unidentified Folding Object BOXABL said the concept was developed by an after-hours skunkworks engineering team and is intended to support future…

TuesdayJun 09, 2026 9:10 am

QualityStocksNewsBreaks – Bank of Japan Sees Growing Upside Inflation Risks Amid Middle East Tensions

Exploring the policies, markets and global events influencing currencies and the movement of money worldwide Bank of Japan Governor Kazuo Ueda said rising crude oil prices are creating upside risks to inflation and could spill over into a broader range of goods and services. The BOJ expects Japan's economy to continue growing despite higher energy costs, supported by strong corporate profits, wage growth and AI-related demand. Ueda indicated the central bank remains prepared to continue raising interest rates if inflation pressures prove more persistent than expected. June 9, 2026 – via CurrencyNewsWire -- Bank of Japan Governor Kazuo Ueda said…

MondayJun 08, 2026 1:15 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation

CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in a virtual investor segment featuring Chief Financial Officer Steve O'Loughlin, who discussed the company's recently completed oversubscribed $22.5 million financing. The presentation focused on the factors supporting the successful capital raise following CNS Pharmaceuticals' strategic reset and acquisition-focused transformation. Management also addressed investor reception to the company's evolving strategy, the participation of healthcare-focused institutional investors and how the strengthened balance sheet positions CNS Pharmaceuticals to pursue potential transformational opportunities. The discussion highlighted the company's long-term growth strategy and efforts to create shareholder value as it advances its next phase of development. To…

MondayJun 08, 2026 9:50 am

QualityStocksNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) Emerging as Mission-Critical AI and Cybersecurity Platform Amid Expanding Government, Defense Opportunities

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) is gaining traction as a specialized artificial intelligence platform serving government, public safety, defense and healthcare markets, leveraging proprietary chemistry-focused AI models, scientific datasets and operational intelligence tools designed for mission-critical environments. The company has established partnerships with Canadian government agencies, law enforcement organizations and public safety initiatives, while advancing defense-related applications through its Q-SAFE hazardous chemical risk classification program and a proposed acquisition of quantum cybersecurity firm Quantum.IQ. Redwood joins a growing group…

MondayJun 08, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for Multiple Sclerosis Treatment

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma’s LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or restoring myelin integrity that affects the loss of mobility or control of a person’s body. The company announced the completion of phase 1 clinical studies involving healthy volunteers, reporting that the therapy demonstrated a favorable safety profile and was generally well tolerated. Quantum BioPharma reached a significant milestone in April 2026 when it announced the submission of an Investigational New Drug application to the U.S. Food…

MondayJun 08, 2026 9:30 am

QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Delivers AI-Powered Threat Detection System Under U.S. Army Contract

Safe Pro Group (NASDAQ: SPAI) announced it has fulfilled a U.S. Army order valued at approximately $743,000 for its AI-powered Threat Analysis Kit, which combines the company’s NODE edge-computing platform with Black Widow(TM) drones from Red Cat Holdings (NASDAQ: RCAT). The field-ready battlefield intelligence system is designed to process drone-captured video and rapidly identify threats such as landmines, unexploded ordnance, cluster munitions and hostile drones, while generating detailed 2D and 3D battlefield maps for situational awareness. The award follows a recent subcontract from a defense prime contractor to provide the U.S. Army with battlefield intelligence capabilities powered by Safe Pro’s…

MondayJun 08, 2026 9:20 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Showcase AI Drug Discovery Platform at Qdrant Vector Space Day 2026

Oncotelic Therapeutics (OTCQB: OTLC) announced that its proprietary PDAOAI(TM) drug discovery and development platform will be featured during the Product & Engineering keynote at Qdrant Vector Space Day 2026 in San Francisco on June 11. Company executives will join Qdrant leadership to discuss how PDAOAI, operating on Qdrant infrastructure, has helped accelerate the development of two drug candidates from concept to investigational new drug filings in less than two years, significantly reducing the time and cost traditionally associated with pharmaceutical development. The presentation will highlight several innovations underpinning the platform, including a proprietary "manifold folding" technique designed to improve semantic…

MondayJun 08, 2026 9:10 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Divests Arizona Lithium Asset to Sharpen Natural Hydrogen Focus

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced an agreement to sell its wholly owned subsidiary, MAX Power Resources LLC, owner of the Willcox Playa Lithium Project in Arizona, to Homeland Critical Minerals Corp. in exchange for 11 million Homeland shares valued at approximately $1.1 million. The transaction aligns with MAX Power’s strategy to concentrate resources on advancing its Natural Hydrogen initiatives while retaining significant exposure to the future development of the Willcox Project through an equity stake representing just under 50%…

MondayJun 08, 2026 9:00 am

QualityStocksNewsBreaks – Microgrids Emerge as Key Solution for AI Data Center Power Demands

Microsoft Corp. (NASDAQ: MSFT) is among the technology companies turning to microgrids as a way to improve energy reliability and resilience for data centers as artificial intelligence workloads drive unprecedented demand for electricity. Microgrids allow facilities to operate independently when disruptions affect local or regional power networks, helping ensure continuous operations while reducing reliance on increasingly strained utility grids. The approach is gaining traction as hyperscalers expand AI infrastructure, particularly in rural areas with limited grid access and in communities where concerns about rising electricity costs and grid upgrades have intensified. Although microgrids require significant upfront investment, many operators view them…

MondayJun 08, 2026 9:00 am

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) Is ‘One to Watch’

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) and may include paid advertising. Redwood AI is developing a proprietary AI platform designed to support drug discovery, synthesis planning, and chemical analysis across pharmaceutical, public safety, defense, and industrial-related markets. The company is positioned across multiple large global market opportunities, including pharmaceutical development, defense-related chemical intelligence, AI-assisted drug discovery, and CDMO infrastructure applications. Reactosphere combines synthesis planning, optimization workflows, sourcing intelligence, and chemical analysis capabilities within a single AI-driven platform. Redwood AI is advancing its AI-powered chemistry platform through research collaborations and government-supported initiatives involving organizations including UBC,…

Site Search

Company Search